Malignant hyperthermia

What is Malignant hyperthermia?

Malignant hyperthermia is a rare but life-threatening reaction to certain drugs used during general anesthesia. It happens when anesthesia drugs trigger a dangerous increase in body temperature and severe muscle contractions. This reaction occurs in people who have inherited a specific genetic mutation that affects how their muscles respond to certain medications.

The condition affects about 1 in 100,000 adults and 1 in 30,000 children who receive anesthesia. When triggered, body temperature can rise rapidly, sometimes reaching 105 degrees Fahrenheit or higher. Muscles break down quickly, releasing harmful substances into the bloodstream. Without immediate treatment, malignant hyperthermia can cause organ damage, brain injury, or death.

Most people with the genetic mutation never know they have it until they receive anesthesia. Family history is the strongest predictor of risk. The condition follows an autosomal dominant pattern, meaning you only need one copy of the mutated gene from one parent to be at risk. If you have the mutation, each of your children has a 50 percent chance of inheriting it.

Suxamethonium (succinylcholine) (rc202) IgE

Pinpoint allergic reactions to Suxamethonium
Clarify unexplained symptoms after anesthesia
Reveal hidden drug sensitivities effortlessly

^$109

Symptoms

Malignant hyperthermia symptoms appear during or shortly after anesthesia exposure. Common signs include:

Rapid rise in body temperature, sometimes 1 to 2 degrees every 5 minutes
Severe muscle rigidity, especially in the jaw
Fast or irregular heartbeat
Rapid breathing or increased carbon dioxide levels
Excessive sweating
Mottled or discolored skin
Dark or cola-colored urine from muscle breakdown
Dangerously high potassium levels in blood
Acid buildup in blood, called metabolic acidosis

Without anesthesia exposure, people with the genetic mutation have no symptoms. The reaction only occurs when triggered by specific anesthetic drugs. Early recognition by medical staff is critical for survival.

Causes and risk factors

Malignant hyperthermia is caused by inherited mutations in genes that control calcium release in muscle cells. The most common mutation affects the RYR1 gene, which accounts for about 70 percent of cases. Other mutations can affect the CACNA1S gene. These genetic changes cause muscle cells to release too much calcium when exposed to triggering drugs, leading to uncontrolled muscle contractions and heat production.

The main triggers are volatile anesthetic gases like sevoflurane, desflurane, and isoflurane, plus the muscle relaxant succinylcholine. Risk factors include having a family history of malignant hyperthermia, unexplained death during anesthesia in a family member, muscle diseases like central core disease, or a personal history of unexplained high fever during surgery. Stress, heat, and intense exercise do not trigger malignant hyperthermia, only specific anesthetic drugs do.

How it's diagnosed

Malignant hyperthermia is primarily diagnosed through genetic testing and specialized muscle biopsy. The gold standard test is called a caffeine halothane contracture test, where a small piece of muscle tissue is exposed to triggering substances in a lab. This test requires a muscle biopsy and is only available at specialized centers. Genetic testing can identify mutations in the RYR1 and CACNA1S genes, confirming susceptibility in about 70 to 80 percent of families with the condition.

Blood tests during an acute episode show signs of muscle breakdown, including elevated creatine kinase, high potassium, and myoglobin in urine. Some people may have allergy testing for anesthetic drugs like succinylcholine, which can show IgE antibodies. However, drug allergy tests do not diagnose malignant hyperthermia susceptibility itself. Talk to a doctor about specialized genetic testing if you have a family history of anesthesia complications.

Treatment options

Treatment for malignant hyperthermia requires immediate medical intervention. Key approaches include:

Stop all triggering anesthetic drugs immediately
Give dantrolene, the only specific treatment that stops the reaction
Cool the body with ice packs, cold intravenous fluids, and cooling blankets
Provide 100 percent oxygen to support breathing
Monitor and correct dangerous electrolyte imbalances, especially high potassium
Support kidney function to prevent damage from muscle breakdown products
Continue dantrolene for 24 to 48 hours to prevent recurrence
Monitor in intensive care for at least 24 hours after stabilization

If you are diagnosed with malignant hyperthermia susceptibility, you need special precautions for any future surgeries. Always inform surgeons and anesthesiologists about your condition. Wear a medical alert bracelet or necklace. Safe anesthesia options exist, including propofol and other non-triggering drugs. Family members should consider genetic testing or muscle biopsy to determine their risk.

Frequently asked questions

Malignant hyperthermia is triggered by specific anesthesia drugs, including volatile gases like sevoflurane, desflurane, and isoflurane, plus the muscle relaxant succinylcholine. These drugs cause abnormal calcium release in muscle cells of genetically susceptible people. Stress, heat, and exercise do not trigger malignant hyperthermia. Only these specific anesthetic medications cause the reaction.

Malignant hyperthermia can develop very rapidly during or shortly after anesthesia exposure. Body temperature can rise 1 to 2 degrees Fahrenheit every 5 minutes. Most reactions occur within the first hour of anesthesia, but some develop several hours after exposure. Early recognition and treatment with dantrolene are critical for survival.

No, malignant hyperthermia is not a true allergic reaction. It is a genetic condition that causes abnormal muscle cell responses to certain drugs. Allergic reactions involve the immune system and IgE antibodies. Malignant hyperthermia involves inherited mutations in genes controlling muscle calcium release. Both can be dangerous, but they require different treatments.

Yes, most people survive malignant hyperthermia with prompt treatment. Before dantrolene was available, the death rate was over 70 percent. Today, with early recognition and dantrolene treatment, the survival rate exceeds 90 percent. Quick action by anesthesia teams saves lives. Delayed treatment increases the risk of organ damage and death.

The gold standard test is a caffeine halothane contracture test, which requires a muscle biopsy analyzed at a specialized center. Genetic testing can identify RYR1 and CACNA1S gene mutations in 70 to 80 percent of susceptible families. Blood tests during an acute episode show muscle breakdown markers like elevated creatine kinase. Family history and genetic counseling help identify at-risk individuals.

Most people do not know they carry the mutation until a reaction occurs during anesthesia. The mutation causes no symptoms without drug exposure. If you have a family history of malignant hyperthermia or unexplained anesthesia complications, ask your doctor about genetic testing before planned surgeries. Knowing your status allows anesthesiologists to use safe alternative drugs.

Many anesthesia options are safe for people with malignant hyperthermia susceptibility. Safe drugs include propofol, ketamine, etomidate, benzodiazepines, opioids, and local anesthetics like lidocaine. Non-triggering muscle relaxants include rocuronium, vecuronium, and atracurium. Your anesthesia team will create a safe plan using only non-triggering medications.

Yes, if you are diagnosed with malignant hyperthermia susceptibility, your blood relatives should consider testing. The condition follows an autosomal dominant pattern, meaning each child has a 50 percent chance of inheriting the mutation. Siblings and parents may also carry the gene. Genetic counseling helps families understand their risk and testing options.

No, malignant hyperthermia only occurs when genetically susceptible people are exposed to specific anesthesia drugs. It does not happen during exercise, hot weather, fever from illness, or emotional stress. People with the mutation live normal lives without symptoms. The reaction requires exposure to triggering anesthetic gases or succinylcholine during medical procedures.

Always inform your surgeon and anesthesiologist about your susceptibility before any procedure. Wear a medical alert bracelet with this information. Bring documentation of your diagnosis, genetic test results, or family history. The anesthesia team will prepare by having dantrolene available, using only safe drugs, and monitoring you closely. With proper precautions, surgery can be performed safely.